TECHWIRE 30
(CIX: WRAL30)  1,115.35  up arrow+4.99  (0.45 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: Apple)  103.30  up arrow+0.8  (0.78 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NY: QUINTILES)  55.88  down arrow-0.24  (-0.43 %)  Updated: 06:40 PM EDT, Sep 02 2014
(OP: BASF SE)  102.55  down arrow-0.35  (-0.34 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: BioCryst)  12.86  down arrow-0.64  (-4.74 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: BioDelivery)  16.65  up arrow+0.65  (4.06 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: CEMP)  10.58  up arrow+0.01  (0.09 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: Cisco Systems)  24.88  down arrow-0.11  (-0.44 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: Cree)  45.13  down arrow-0.43  (-0.94 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: DARA)  1.25  up arrow+0.01  (0.4 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NY: EMC CORPORATION)  29.43  down arrow-0.1  (-0.34 %)  Updated: 06:40 PM EDT, Sep 02 2014
(NQ: Extreme Networks)  5.27  down arrow-0.06  (-1.13 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: FB)  76.68  up arrow+1.86  (2.49 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NY: GLAXOSMITHKLINE)  48.29  down arrow-0.81  (-1.65 %)  Updated: 06:40 PM EDT, Sep 02 2014
(NQ: GOOG)  577.33  up arrow+5.73  (1 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NY: IBM)  191.56  down arrow-0.74  (-0.38 %)  Updated: 06:40 PM EDT, Sep 02 2014
(NY: LH)  106.55  down arrow-0.68  (-0.63 %)  Updated: 06:40 PM EDT, Sep 02 2014
(OP: Lenovo Group)  31.47  up arrow+0.95  (3.11 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NY: MRK)  59.79  down arrow-0.32  (-0.53 %)  Updated: 06:40 PM EDT, Sep 02 2014
(NQ: Microsoft Corp)  45.09  down arrow-0.34  (-0.75 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: NTAP)  42.04  down arrow-0.12  (-0.28 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NY: NOVARTIS AG)  93.71  up arrow+3.87  (4.31 %)  Updated: 06:40 PM EDT, Sep 02 2014
(OP: Novozymes A/S)  46.41  up arrow+0.17  (0.37 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NY: PFIZER)  29.26  down arrow-0.13  (-0.44 %)  Updated: 06:40 PM EDT, Sep 02 2014
(NQ: Pozen)  8.33  up arrow+0.03  (0.36 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NY: RED HAT)  61.30  up arrow+0.38  (0.62 %)  Updated: 06:40 PM EDT, Sep 02 2014
(NQ: BBRY)  10.45  up arrow+0.27  (2.65 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: Salix)  159.00  down arrow-0.11  (-0.07 %)  Updated: 08:10 PM EDT, Sep 02 2014
(NQ: SQI)  16.33  up arrow+0.36  (2.25 %)  Updated: 08:10 PM EDT, Sep 02 2014

Posts tagged “Biotech & Life Science”

Updated 7:20 a.m. yesterday

Premium Lock Dignify Therapeutics wins SBIR grant, aims for $3M in funding

Dignify Therapeutics The drug development company focused on restoring bladder and bowel control to people with spinal injuries has been awarded $159,000 Small Business Innovation Research (SBIR) grant as global market potential for their flagship product continues to grow.

7:04 a.m. yesterday

Holiday catch up: More than 50 WRAL TechWire headlines from last week

Week in review Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with more than 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.

6:54 a.m. yesterday

Your company making news? Share it with WRAL TechWire

Contribute to WRALTechWire WRAL TechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

August 30

Experimental Ebola drug heals all monkeys in study

Ebola fight   An experimental Ebola drug healed all 18 monkeys infected with the deadly virus in a study, boosting hopes that the treatment might help fight the outbreak raging through West Africa -- once more of it can be made.

August 29

US funds another $2.4M for Ebola vaccine work at BioCryst

The National Institute of Allergy and Infectious Diseases has provided another $2.4 million in funding to Triangle-based BioCryst Pharmaceuticals for further development of a potential vaccine to treat Ebola. It's part of a global ramping up to fight the Ebola outbreak in West Africa.

Ebola virus   Ebola virus

August 29

US to begin tests of GSK's Ebola vaccine next week

The National Institutes of Health announced Thursday that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline. Beginning Tuesday, it will test 20 healthy adult volunteers to see if the virus is safe and triggers an adequate response in their immune systems.

Ebola Genome Ebola Genome

Updated August 28

US to test GSK's vaccine for Ebola; Greenville lab could produce a treatment

A possible vaccine to treat the spreading Ebola outbreak in Africa could be coming from GSK. Plus, a lab in Greenville could be a site where a treatment is produced.

Ebola virus   Ebola virus

Updated August 27

Premium Lock Rather than 'build,' Premier does a 'buy' in $48.5M cash deal for Raleigh-based Aperek

Charlotte-based Premier Inc., which works with healthcare clients to improve purchasing and internal performance, has been on an acquisition hunt in recent months. And Raleigh-based Aperek is the latest at a price of $48.5 million. Premier's CEO explains her thinking in making the deal.

Premier Premier

Updated August 27

Premier, Inc. acquires Raleigh-base supply chain software firm Aperek for $48.5M

Healthcare    Aperek, which formerly was known as Mediclick and focuses on supply chain software solutions for the healthcare industry, is being acquired by Charlotte-based Premier, Inc. in a deal valued at $48.5 million.

Updated August 26

Red Hat beefs up 'cloud;' Heat Bio-Square 1 $7.5M deal; VM vs. EMC?; Tivo's non-cable recorder

Bulldog In the latest Bulldog wrapup of technology and life science news: Red Hat unveils new cloud product; Heat Biologics lands $7.5 million in financing from Square 1; VMware targets cloud; Tivo's new recorder for "cord-cutters."

August 25

Premium Lock Argos formally picks Durham for HQ, signs 10-year lease

Argos Therapeutics, which went public earlier this year, has formally committed to making Durham its headquarters. In an SEC filing, the company discloses it has signed a 10-year lease at $61,750 for a new building.

Argos' immunotherapy process Argos' immunotherapy process

August 25

Roche to buy biotech firm InterMune for $8.3 billion

Switzerland Roche InterMune Swiss pharmaceutical company Roche said Sunday it has reached an $8.3 billion deal to buy InterMune Inc., a California-based developer of treatments for lung diseases.

Updated August 25

Have news? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

August 25

Your 51 WRAL TechWire headlines from last week

Week in review Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with more than 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.

August 22

Doctor who survived Ebola: 'Please continue to pray for Liberia and the people of West Africa ...'

As one of few Ebola survivors with medical expertise, Dr. Kent Brantly seems keenly aware of the position his painful experience has put him in. He hasn't spoken yet about his plans, but spent much of his first public appearance pleading for help for countries still struggling with the virus.

Americans Ebola Americans Ebola

August 22

Premium Lock Exclusive: New Biotech Center CEO will 'push the envelope with new ideas and programs'

In the second part of an exclusive in-depth Q&A with Doug Edgeton, the new CEO of the North Carolina Biotechnology Center, the veteran life science executive talks about his goals, his background, and the Center's commitment to development of the sector across the state.

Douge Edgeton  Douge Edgeton

August 22

Premium Lock Exclusive: New Biotech Center CEO lays out future vision

Life science veteran executive Doug Edgeton, who once ran the Piedmont Research Park in Winston-Salem, spells out his vision for where he hopes to take the North Carolina Biotechnology Center as its new CEO in an exclusive Q&A with WRAL Tech Wire. He says N.C. has a fight on its hands to grow one of the nation's largest biotech industry clusters. But Edgeton believes he's ready for the job. Restoring state budget cuts is a "top priority" as well as recruiting and helping build new businesses. "We have to be creative in finding ways to bring technologies to the marketplace that will improve lives, create well-paying jobs and create wealth for the people of our state," Edgeton explains.

Doug Edgeton Doug Edgeton

August 21

Premium Lock Clinverse CEO: Pharma industry changes mean more business opportunities

Denis Connaghan, Clinverse's chief executive officer, has $9.1 million in new funding to exploit changes in the pharmaceutical business that mean more opportunities for his clinical trials technology firm. He also talks about the challenges he has faced in his first year on the job in an exclusive Q&A for WRAL TechWire Insiders.

Clinverse Clinverse

August 21

$15M Marcus Foundation grant boosts cord blood research at Duke

The Duke award enables cell therapy expert Joanne Kurtzberg, M.D., and leading autism authority Geraldine Dawson, Ph.D., professor of psychiatry and behavioral sciences, to pioneer new treatment approaches and cell-based therapies that could potentially benefit many autism patients.

Home Depot co-founder, philanthropist Bernie Marcus. Home Depot co-founder, philanthropist Bernie Marcus.

Updated August 20

More than 60 startups join lineup for Tech Venture 2014

CED Tech Venture Conference The Council for Entrepreneurial development is going to swamp attendees at its annual venture conference with startup and emerging companies that just might be worth investment. The list of presenting companies grew to more than 60 with the list announced Wednesday.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll